Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. (CATX) is a Medical devices company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Perspective Therapeutics, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
- Sector
- Healthcare
- Industry
- Medical devices
- Country
- United States
- Exchange
- New York Stock Exchange
- CEO
- Johan Spoor
- Employees
- 138
- IPO date
- 10 Nov 2005
- ISIN
- US46489V3024
- Website
- perspectivetherapeutics.com
Frequently asked questions
Where is Perspective Therapeutics, Inc. stock listed?
Perspective Therapeutics, Inc. (CATX) is listed on New York Stock Exchange.